HHealth Read More UVA researcher wins $700,000 for promising ovarian cancer researchJanuary 8, 2026 Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has won…
MMedication Read More Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with HypercortisolismDecember 31, 2025 REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…
CCelebrities Read More Angelina Jolie Details Decision to Reveal Double Mastectomy Scars For the First TimeDecember 16, 2025 “I share these scars with many women I love,” wrote the Oscar winner, who underwent a double mastectomy…
BBusiness Read More Jury says Johnson & Johnson owes $40M to 2 cancer patients who used talcum powdersDecember 13, 2025 A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made…
HHealthcare Read More What we know as Johnson & Johnson sued by thousands in UK over talcum powderOctober 16, 2025 Thousands of people are launching a collective legal challenge against healthcare giant Johnson & Johnson (J&J), claiming it…
HHealthcare Read More Advanced prostate cancer drug combo found to be effectiveOctober 11, 2025 A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug…
GGenetics Read More Breast Cancer Awareness | Genetic testing a crucial tool in detection, treatment | NewsOctober 1, 2025 INDIANA, Pa. – As the genetic coordinator at Indiana Regional Medical Center’s Comprehensive Breast Center, Dawn Zarycki is…
HHealth Read More Peer networks drive use of opportunistic salpingectomy for ovarian cancer preventionSeptember 30, 2025 Peer networks drive use of opportunistic salpingectomy for ovarian cancer prevention | Image Credit: © N Felix/peopleimages.com –…
HHealth Read More Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasisSeptember 23, 2025 Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates…
GGenetics Read More Empowerment Through DNA Knowledge – Saucon SourceSeptember 16, 2025 Jessica Burke of Allentown remembered she previously signed up to participate in the St. Luke’s DNA Answers research…
BBusiness Read More Evolving Surgical Strategies and the Role of Mirvetuximab Soravtansine Shape the Ovarian Cancer Treatment ParadigmSeptember 11, 2025 Ryan M. Kahn, MD, MHS, FACOG As surgical modalities and treatments for ovarian cancer continue to advance, an…